Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 299

1.

Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma.

Tatsumi T, Yamamoto S, Uehara J, Sugawara T, Baba T, Inoue M, Hata H, Mitamura Y.

Graefes Arch Clin Exp Ophthalmol. 2013 May;251(5):1355-60. doi: 10.1007/s00417-012-2236-9. Epub 2012 Dec 19.

PMID:
23250484
2.

Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma.

Ciftci S, Sakalar YB, Unlu K, Keklikci U, Caca I, Dogan E.

Eur J Ophthalmol. 2009 Nov-Dec;19(6):1028-33.

PMID:
19882572
3.

Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.

Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F, Otori Y, Kamei M, Kusaka S, Tano Y.

Ophthalmology. 2008 Sep;115(9):1571-80, 1580.e1-3. doi: 10.1016/j.ophtha.2008.02.026. Epub 2008 Apr 28.

PMID:
18440643
4.

Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.

Eid TM, Radwan A, el-Manawy W, el-Hawary I.

Can J Ophthalmol. 2009 Aug;44(4):451-6. doi: 10.3129/i09-108.

PMID:
19606170
5.

Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.

Alkawas AA, Shahien EA, Hussein AM.

J Glaucoma. 2010 Dec;19(9):622-6. doi: 10.1097/IJG.0b013e3181ccb794.

PMID:
20179624
6.

Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab.

Wittström E, Holmberg H, Hvarfner C, Andréasson S.

Eur J Ophthalmol. 2012 Jul-Aug;22(4):563-74. doi: 10.5301/ejo.5000089.

PMID:
22139613
7.

Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by Ahmed valve implantation in neovascular glaucoma.

Mahdy RA, Nada WM, Fawzy KM, Alnashar HY, Almosalamy SM.

J Glaucoma. 2013 Dec;22(9):768-72. doi: 10.1097/IJG.0b013e318259aec4.

PMID:
22790513
8.

Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.

Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM.

Am J Ophthalmol. 2006 Dec;142(6):1054-6. Epub 2006 Aug 2.

PMID:
17157590
9.

Full preoperative panretinal photocoagulation improves the outcome of trabeculectomy with mitomycin C for neovascular glaucoma.

Al Obeidan SA, Osman EA, Al-Amro SA, Kangave D, Abu El-Asrar AM.

Eur J Ophthalmol. 2008 Sep-Oct;18(5):758-64.

PMID:
18850555
10.

Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.

Ehlers JP, Spirn MJ, Lam A, Sivalingam A, Samuel MA, Tasman W.

Retina. 2008 May;28(5):696-702. doi: 10.1097/IAE.0b013e3181679c0b.

PMID:
18463512
11.

Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.

Moraczewski AL, Lee RK, Palmberg PF, Rosenfeld PJ, Feuer WJ.

Br J Ophthalmol. 2009 May;93(5):589-93. doi: 10.1136/bjo.2008.151472. Epub 2008 Dec 15.

PMID:
19074917
12.

Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma.

Takihara Y, Inatani M, Kawaji T, Fukushima M, Iwao K, Iwao M, Tanihara H.

J Glaucoma. 2011 Mar;20(3):196-201. doi: 10.1097/IJG.0b013e3181d9ce12.

PMID:
20440215
13.

Long-term results of Ahmed glaucoma valve in association with intravitreal bevacizumab in neovascular glaucoma.

Sahyoun M, Azar G, Khoueir Z, Antoun J, Kourie H, Nehme J, Jalkh A.

J Glaucoma. 2015 Jun-Jul;24(5):383-8. doi: 10.1097/IJG.0000000000000234.

PMID:
25719230
14.

Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma.

Ma KT, Yang JY, Kim JH, Kim NR, Hong S, Lee ES, Seong GJ, Kim CY.

J Glaucoma. 2012 Jun-Jul;21(5):331-6. doi: 10.1097/IJG.0b013e31820e2fd0.

PMID:
21673594
15.

Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma.

Kitnarong N, Chindasub P, Metheetrairut A.

Adv Ther. 2008 May;25(5):438-43. doi: 10.1007/s12325-008-0047-5.

PMID:
18425438
16.

Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis.

Nakatake S, Yoshida S, Nakao S, Arita R, Yasuda M, Kita T, Enaida H, Ohshima Y, Ishibashi T.

BMC Ophthalmol. 2014 Apr 26;14:55. doi: 10.1186/1471-2415-14-55.

17.

Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma.

Kiuchi Y, Nakae K, Saito Y, Ito S, Ito N.

Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1627-32.

PMID:
16639623
18.

Intravitreal bevacizumab for neovascular glaucoma.

Vasudev D, Blair MP, Galasso J, Kapur R, Vajaranant T.

J Ocul Pharmacol Ther. 2009 Oct;25(5):453-8. doi: 10.1089/jop.2009.0036.

19.

The effect of intravitreal bevacizumab injection before Ahmed valve implantation in patients with neovascular glaucoma.

Kang JY, Nam KY, Lee SJ, Lee SU.

Int Ophthalmol. 2014 Aug;34(4):793-9. doi: 10.1007/s10792-013-9875-7. Epub 2013 Nov 2.

PMID:
24186000
20.

[Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].

Douat J, Auriol S, Mahieu-Durringer L, Ancèle E, Pagot-Mathis V, Mathis A.

J Fr Ophtalmol. 2009 Nov;32(9):652-63. doi: 10.1016/j.jfo.2009.10.001. Epub 2009 Nov 4. French.

Supplemental Content

Support Center